Predictions
Biogen Inc.
Start price
Target price
Perf. (%)
€91.50
22.01.12
22.01.12
€100.00
23.07.12
23.07.12
29.40%
23.07.12
23.07.12
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€91.50
22.01.12
22.01.12
€100.00
23.07.12
23.07.12
29.40%
23.07.12
23.07.12
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€91.50
22.01.12
22.01.12
€100.00
23.07.12
23.07.12
29.40%
23.07.12
23.07.12
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€49.74
07.04.12
07.04.12
€55.01
05.07.12
05.07.12
11.87%
05.07.12
05.07.12
Johnson & Johnson
Start price
Target price
Perf. (%)
€49.74
07.04.12
07.04.12
€55.01
05.07.12
05.07.12
11.87%
05.07.12
05.07.12
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.20
12.04.12
12.04.12
€34.00
07.05.12
07.05.12
59.14%
07.05.12
07.05.12
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.20
12.04.12
12.04.12
€34.00
07.05.12
07.05.12
59.14%
07.05.12
07.05.12
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.20
12.04.12
12.04.12
€34.00
07.05.12
07.05.12
59.14%
07.05.12
07.05.12
Abbott Laboratories
Start price
Target price
Perf. (%)
€34.75
21.08.11
21.08.11
€37.00
13.02.12
13.02.12
22.72%
13.02.12
13.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.59
15.10.11
15.10.11
€18.65
01.02.12
01.02.12
27.94%
01.02.12
01.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.59
15.10.11
15.10.11
€18.65
01.02.12
01.02.12
27.94%
01.02.12
01.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.59
15.10.11
15.10.11
€18.65
01.02.12
01.02.12
27.94%
01.02.12
01.02.12
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€14.68
27.07.11
27.07.11
€18.00
26.01.12
26.01.12
25.99%
26.01.12
26.01.12
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued